Clover Health Investments Corp
$ 2.51
-0.79%
26 Dec - close price
- Market Cap 1,296,862,000 USD
- Current Price $ 2.51
- High / Low $ 2.55 / 2.50
- Stock P/E N/A
- Book Value 0.66
- EPS -0.11
- Next Earning Report 2026-03-04
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.06 %
- ROE -0.17 %
- 52 Week High 4.87
- 52 Week Low 2.12
About
Clover Health Investments Corp. is a pioneering health insurance provider headquartered in Franklin, Tennessee, dedicated to offering technology-driven healthcare solutions tailored for Medicare-eligible individuals. The company leverages its proprietary Clover Assistant platform to deliver personalized medical insights and advanced data analytics, significantly improving patient outcomes while maintaining cost effectiveness. As a leader in the health tech sector, Clover Health is strategically positioned to capitalize on the increasing demand for value-based care, making it an attractive investment opportunity for institutional investors seeking exposure in the rapidly growing Medicare Advantage market.
Analyst Target Price
$3.23
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-04 | 2025-08-04 | 2025-05-05 | 2025-03-10 | 2024-11-06 | 2024-08-05 | 2024-05-07 | 2024-03-12 | 2023-11-06 | 2023-08-08 | 2023-05-09 | 2023-02-28 |
| Reported EPS | -0.05 | 0.0329 | 0.051 | -0.05 | -0.02 | 0.01 | -0.04 | -0.14 | -0.09 | -0.06 | -0.15 | -0.17 |
| Estimated EPS | -0.01 | -0.0187 | -0.07 | -0.065 | -0.04 | -0.05 | -0.07 | -0.14 | -0.11 | -0.15 | -0.18 | -0.26 |
| Surprise | -0.04 | 0.0516 | 0.121 | 0.015 | 0.02 | 0.06 | 0.03 | 0 | 0.02 | 0.09 | 0.03 | 0.09 |
| Surprise Percentage | -400% | 275.9358% | 172.8571% | 23.0769% | 50% | 120% | 42.8571% | 0% | 18.1818% | 60% | 16.6667% | 34.6154% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-04 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -0.0545 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CLOV
2025-12-19 00:09:10
Clover Health Investments, Corp. (NASDAQ:CLOV) has received a consensus "Hold" recommendation from analysts, with an average 12-month price target of $3.23. The company recently missed EPS expectations but exceeded revenue forecasts, while institutional investors have adjusted their positions in the stock. CLOV shares are currently trading around $2.64 with a market capitalization of $1.36 billion.
2025-12-15 01:09:53
Rhumbline Advisers significantly increased its stake in Clover Health Investments (NASDAQ:CLOV) by 8,149.2% in the second quarter, now holding 584,459 shares valued at $1.63 million. Despite this increased institutional interest, analysts maintain a "Hold" consensus rating with a target price of $3.93, while the company faces challenges with missed EPS estimates and negative profitability metrics. Several other institutional investors also acquired new positions in CLOV during recent quarters, indicating varied sentiment towards the stock.
2025-12-11 03:09:10
Soviero Asset Management LP significantly increased its stake in Clover Health Investments, Corp. (NASDAQ:CLOV) by 260%, acquiring an additional 650,000 shares to total 900,000 shares worth approximately $2.51 million. Despite a recent EPS miss, the company reported revenue of $496.65 million, surpassing expectations. Analysts currently have a "Hold" consensus rating for CLOV, with an average price target of $3.93.
2025-11-23 02:09:38
Clover Health Investments, Corp. (NASDAQ:CLOV) has received a "Moderate Buy" consensus recommendation from six analysts, with an average 12-month price target of $3.93. The company recently reported a quarterly EPS of ($0.05), missing estimates, but revenue beat expectations at $496.65 million. Institutional investors have been increasing their stakes, and the stock currently trades around $2.28.
2025-11-21 04:08:50
Clover Health's CFO, Peter Kuipers, is scheduled to present at the 2025 Citi Global Healthcare Conference on December 4, 2025. The presentation will discuss the company's focus on improving healthcare access for Medicare beneficiaries through its Clover Assistant software platform. This engagement aims to increase investor visibility and highlight Clover Health's technological advancements and commitment to enhancing patient outcomes.
2025-11-19 02:09:38
Clover Health Investments (CLOV) reported break-even quarterly earnings, surpassing the Zacks Consensus Estimate of a $0.02 loss per share for Q3 2025, and also exceeded revenue expectations with $496.65 million. The company has shown favorable estimate revisions recently, earning a Zacks Rank #2 (Buy), suggesting potential market outperformance. This positive outlook is supported by a 16.8% stock gain year-to-date, slightly outpacing the S&P 500.
